nodes	percent_of_prediction	percent_of_DWPC	metapath
Sunitinib—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.0691	0.235	CbGbCtD
Sunitinib—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.0625	0.212	CbGbCtD
Sunitinib—CYP3A7—Cyclosporine—focal segmental glomerulosclerosis	0.0462	0.157	CbGbCtD
Sunitinib—CYP3A7-CYP3A51P—Cyclosporine—focal segmental glomerulosclerosis	0.0462	0.157	CbGbCtD
Sunitinib—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0346	0.118	CbGbCtD
Sunitinib—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0225	0.0765	CbGbCtD
Sunitinib—Blindness cortical—Cyclosporine—focal segmental glomerulosclerosis	0.0158	0.097	CcSEcCtD
Sunitinib—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0135	0.0458	CbGbCtD
Sunitinib—Thrombotic microangiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0119	0.0729	CcSEcCtD
Sunitinib—Posterior reversible encephalopathy syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00906	0.0557	CcSEcCtD
Sunitinib—STK39—nephron—focal segmental glomerulosclerosis	0.00906	0.0389	CbGeAlD
Sunitinib—ERN1—endothelium—focal segmental glomerulosclerosis	0.00658	0.0282	CbGeAlD
Sunitinib—Hyperkeratosis—Cyclosporine—focal segmental glomerulosclerosis	0.0052	0.032	CcSEcCtD
Sunitinib—Skin infection—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.0303	CcSEcCtD
Sunitinib—Pigmentation disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00445	0.0274	CcSEcCtD
Sunitinib—MYLK—endothelium—focal segmental glomerulosclerosis	0.00416	0.0178	CbGeAlD
Sunitinib—Bacterial infection—Cyclosporine—focal segmental glomerulosclerosis	0.00322	0.0198	CcSEcCtD
Sunitinib—MYLK4—cortex of kidney—focal segmental glomerulosclerosis	0.00316	0.0136	CbGeAlD
Sunitinib—PRKAA2—nephron tubule—focal segmental glomerulosclerosis	0.00301	0.0129	CbGeAlD
Sunitinib—FLT4—endothelium—focal segmental glomerulosclerosis	0.00298	0.0128	CbGeAlD
Sunitinib—PIP4K2B—kidney—focal segmental glomerulosclerosis	0.00265	0.0114	CbGeAlD
Sunitinib—CDK14—nephron tubule—focal segmental glomerulosclerosis	0.00263	0.0113	CbGeAlD
Sunitinib—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00262	0.0161	CcSEcCtD
Sunitinib—PRKAA2—cortex of kidney—focal segmental glomerulosclerosis	0.00258	0.0111	CbGeAlD
Sunitinib—CLK4—nephron tubule—focal segmental glomerulosclerosis	0.00247	0.0106	CbGeAlD
Sunitinib—FLT1—endothelium—focal segmental glomerulosclerosis	0.00232	0.00994	CbGeAlD
Sunitinib—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.0141	CcSEcCtD
Sunitinib—RPS6KA1—nephron tubule—focal segmental glomerulosclerosis	0.00228	0.0098	CbGeAlD
Sunitinib—CDK16—kidney—focal segmental glomerulosclerosis	0.00228	0.00979	CbGeAlD
Sunitinib—CDK14—cortex of kidney—focal segmental glomerulosclerosis	0.00225	0.00967	CbGeAlD
Sunitinib—LATS2—cortex of kidney—focal segmental glomerulosclerosis	0.00222	0.00954	CbGeAlD
Sunitinib—ICK—nephron tubule—focal segmental glomerulosclerosis	0.0022	0.00943	CbGeAlD
Sunitinib—CLK4—kidney—focal segmental glomerulosclerosis	0.00217	0.0093	CbGeAlD
Sunitinib—NUAK1—nephron tubule—focal segmental glomerulosclerosis	0.00212	0.00911	CbGeAlD
Sunitinib—Myopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.013	CcSEcCtD
Sunitinib—CLK4—cortex of kidney—focal segmental glomerulosclerosis	0.00211	0.00906	CbGeAlD
Sunitinib—OXSR1—nephron tubule—focal segmental glomerulosclerosis	0.00211	0.00904	CbGeAlD
Sunitinib—INSR—nephron tubule—focal segmental glomerulosclerosis	0.00211	0.00904	CbGeAlD
Sunitinib—Thrombosis—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.0129	CcSEcCtD
Sunitinib—RPS6KA2—nephron tubule—focal segmental glomerulosclerosis	0.00207	0.00889	CbGeAlD
Sunitinib—STK38—nephron tubule—focal segmental glomerulosclerosis	0.00207	0.00889	CbGeAlD
Sunitinib—DAPK1—cortex of kidney—focal segmental glomerulosclerosis	0.00204	0.00875	CbGeAlD
Sunitinib—BRD4—kidney—focal segmental glomerulosclerosis	0.00203	0.0087	CbGeAlD
Sunitinib—PRPF4—nephron tubule—focal segmental glomerulosclerosis	0.00201	0.00863	CbGeAlD
Sunitinib—PRPF4B—nephron tubule—focal segmental glomerulosclerosis	0.00198	0.00851	CbGeAlD
Sunitinib—BRD4—cortex of kidney—focal segmental glomerulosclerosis	0.00197	0.00847	CbGeAlD
Sunitinib—KDR—endothelium—focal segmental glomerulosclerosis	0.00196	0.0084	CbGeAlD
Sunitinib—STK39—nephron tubule—focal segmental glomerulosclerosis	0.00196	0.00839	CbGeAlD
Sunitinib—RPS6KA1—cortex of kidney—focal segmental glomerulosclerosis	0.00195	0.00839	CbGeAlD
Sunitinib—CSNK2A1—nephron tubule—focal segmental glomerulosclerosis	0.00193	0.00828	CbGeAlD
Sunitinib—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0118	CcSEcCtD
Sunitinib—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.0118	CcSEcCtD
Sunitinib—MYLK—nephron tubule—focal segmental glomerulosclerosis	0.0019	0.00817	CbGeAlD
Sunitinib—SGK3—cortex of kidney—focal segmental glomerulosclerosis	0.0019	0.00815	CbGeAlD
Sunitinib—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0116	CcSEcCtD
Sunitinib—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0116	CcSEcCtD
Sunitinib—ICK—cortex of kidney—focal segmental glomerulosclerosis	0.00188	0.00807	CbGeAlD
Sunitinib—Abscess—Cyclosporine—focal segmental glomerulosclerosis	0.00188	0.0116	CcSEcCtD
Sunitinib—INSR—kidney—focal segmental glomerulosclerosis	0.00185	0.00794	CbGeAlD
Sunitinib—SNRK—kidney—focal segmental glomerulosclerosis	0.00185	0.00794	CbGeAlD
Sunitinib—OXSR1—kidney—focal segmental glomerulosclerosis	0.00185	0.00794	CbGeAlD
Sunitinib—NUAK1—cortex of kidney—focal segmental glomerulosclerosis	0.00182	0.0078	CbGeAlD
Sunitinib—INSR—cortex of kidney—focal segmental glomerulosclerosis	0.0018	0.00773	CbGeAlD
Sunitinib—OXSR1—cortex of kidney—focal segmental glomerulosclerosis	0.0018	0.00773	CbGeAlD
Sunitinib—SNRK—cortex of kidney—focal segmental glomerulosclerosis	0.0018	0.00773	CbGeAlD
Sunitinib—PKN1—kidney—focal segmental glomerulosclerosis	0.00179	0.0077	CbGeAlD
Sunitinib—STK38—cortex of kidney—focal segmental glomerulosclerosis	0.00177	0.00761	CbGeAlD
Sunitinib—RPS6KA2—cortex of kidney—focal segmental glomerulosclerosis	0.00177	0.00761	CbGeAlD
Sunitinib—PRPF4—kidney—focal segmental glomerulosclerosis	0.00177	0.00758	CbGeAlD
Sunitinib—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.0109	CcSEcCtD
Sunitinib—HIPK3—nephron tubule—focal segmental glomerulosclerosis	0.00177	0.00758	CbGeAlD
Sunitinib—HIPK2—nephron tubule—focal segmental glomerulosclerosis	0.00177	0.00758	CbGeAlD
Sunitinib—RIOK2—nephron tubule—focal segmental glomerulosclerosis	0.00175	0.0075	CbGeAlD
Sunitinib—CSNK1G2—cortex of kidney—focal segmental glomerulosclerosis	0.00175	0.00749	CbGeAlD
Sunitinib—PRPF4B—kidney—focal segmental glomerulosclerosis	0.00174	0.00747	CbGeAlD
Sunitinib—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.0107	CcSEcCtD
Sunitinib—KIT—endothelium—focal segmental glomerulosclerosis	0.00174	0.00745	CbGeAlD
Sunitinib—PRPF4—cortex of kidney—focal segmental glomerulosclerosis	0.00172	0.00738	CbGeAlD
Sunitinib—STK39—kidney—focal segmental glomerulosclerosis	0.00172	0.00737	CbGeAlD
Sunitinib—PRPF4B—cortex of kidney—focal segmental glomerulosclerosis	0.0017	0.00728	CbGeAlD
Sunitinib—CSNK2A1—kidney—focal segmental glomerulosclerosis	0.0017	0.00727	CbGeAlD
Sunitinib—Rhabdomyolysis—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.0103	CcSEcCtD
Sunitinib—MYLK—kidney—focal segmental glomerulosclerosis	0.00167	0.00718	CbGeAlD
Sunitinib—STK39—cortex of kidney—focal segmental glomerulosclerosis	0.00167	0.00718	CbGeAlD
Sunitinib—CSNK2A1—cortex of kidney—focal segmental glomerulosclerosis	0.00165	0.00709	CbGeAlD
Sunitinib—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0101	CcSEcCtD
Sunitinib—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.0101	CcSEcCtD
Sunitinib—Cellulitis—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.0101	CcSEcCtD
Sunitinib—MYLK—cortex of kidney—focal segmental glomerulosclerosis	0.00163	0.00699	CbGeAlD
Sunitinib—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00992	CcSEcCtD
Sunitinib—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00992	CcSEcCtD
Sunitinib—Hyperuricaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0016	0.00986	CcSEcCtD
Sunitinib—STK24—cortex of kidney—focal segmental glomerulosclerosis	0.00156	0.00671	CbGeAlD
Sunitinib—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00156	0.00961	CcSEcCtD
Sunitinib—HIPK3—kidney—focal segmental glomerulosclerosis	0.00155	0.00666	CbGeAlD
Sunitinib—HIPK2—kidney—focal segmental glomerulosclerosis	0.00155	0.00666	CbGeAlD
Sunitinib—DAPK2—cortex of kidney—focal segmental glomerulosclerosis	0.00155	0.00663	CbGeAlD
Sunitinib—MAP4K4—nephron tubule—focal segmental glomerulosclerosis	0.00152	0.00654	CbGeAlD
Sunitinib—Blood uric acid increased—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00931	CcSEcCtD
Sunitinib—NUAK2—nephron tubule—focal segmental glomerulosclerosis	0.00151	0.00649	CbGeAlD
Sunitinib—HIPK2—cortex of kidney—focal segmental glomerulosclerosis	0.00151	0.00649	CbGeAlD
Sunitinib—RIOK2—cortex of kidney—focal segmental glomerulosclerosis	0.0015	0.00642	CbGeAlD
Sunitinib—RPS6KA3—nephron tubule—focal segmental glomerulosclerosis	0.00148	0.00636	CbGeAlD
Sunitinib—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00898	CcSEcCtD
Sunitinib—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00898	CcSEcCtD
Sunitinib—CSNK1A1—nephron tubule—focal segmental glomerulosclerosis	0.00145	0.00623	CbGeAlD
Sunitinib—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00888	CcSEcCtD
Sunitinib—CLK1—nephron tubule—focal segmental glomerulosclerosis	0.00144	0.00619	CbGeAlD
Sunitinib—CLK2—cortex of kidney—focal segmental glomerulosclerosis	0.00144	0.00618	CbGeAlD
Sunitinib—ROCK1—kidney—focal segmental glomerulosclerosis	0.00143	0.00615	CbGeAlD
Sunitinib—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00873	CcSEcCtD
Sunitinib—STK3—cortex of kidney—focal segmental glomerulosclerosis	0.00141	0.00606	CbGeAlD
Sunitinib—DYRK1A—kidney—focal segmental glomerulosclerosis	0.0014	0.00599	CbGeAlD
Sunitinib—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00836	CcSEcCtD
Sunitinib—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00827	CcSEcCtD
Sunitinib—MAP4K4—kidney—focal segmental glomerulosclerosis	0.00134	0.00575	CbGeAlD
Sunitinib—RPS6KA3—kidney—focal segmental glomerulosclerosis	0.0013	0.00559	CbGeAlD
Sunitinib—NUAK2—cortex of kidney—focal segmental glomerulosclerosis	0.00129	0.00556	CbGeAlD
Sunitinib—MAP2K1—kidney—focal segmental glomerulosclerosis	0.00129	0.00555	CbGeAlD
Sunitinib—Sepsis—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00793	CcSEcCtD
Sunitinib—MAP3K2—nephron tubule—focal segmental glomerulosclerosis	0.00129	0.00552	CbGeAlD
Sunitinib—CSNK1A1—kidney—focal segmental glomerulosclerosis	0.00128	0.00548	CbGeAlD
Sunitinib—CLK1—kidney—focal segmental glomerulosclerosis	0.00127	0.00544	CbGeAlD
Sunitinib—RPS6KA3—cortex of kidney—focal segmental glomerulosclerosis	0.00127	0.00544	CbGeAlD
Sunitinib—TBK1—nephron tubule—focal segmental glomerulosclerosis	0.00126	0.00541	CbGeAlD
Sunitinib—TYK2—nephron tubule—focal segmental glomerulosclerosis	0.00125	0.00537	CbGeAlD
Sunitinib—CSNK1A1—cortex of kidney—focal segmental glomerulosclerosis	0.00124	0.00533	CbGeAlD
Sunitinib—CLK1—cortex of kidney—focal segmental glomerulosclerosis	0.00124	0.0053	CbGeAlD
Sunitinib—IRAK1—nephron tubule—focal segmental glomerulosclerosis	0.00124	0.0053	CbGeAlD
Sunitinib—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00759	CcSEcCtD
Sunitinib—LRRK2—kidney—focal segmental glomerulosclerosis	0.00123	0.00529	CbGeAlD
Sunitinib—PRKAA1—kidney—focal segmental glomerulosclerosis	0.00122	0.00522	CbGeAlD
Sunitinib—CAMK2G—cortex of kidney—focal segmental glomerulosclerosis	0.00121	0.0052	CbGeAlD
Sunitinib—PTK2B—kidney—focal segmental glomerulosclerosis	0.0012	0.00516	CbGeAlD
Sunitinib—LRRK2—cortex of kidney—focal segmental glomerulosclerosis	0.0012	0.00516	CbGeAlD
Sunitinib—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00739	CcSEcCtD
Sunitinib—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.00739	CcSEcCtD
Sunitinib—FLT4—cortex of kidney—focal segmental glomerulosclerosis	0.00117	0.00501	CbGeAlD
Sunitinib—SLK—nephron tubule—focal segmental glomerulosclerosis	0.00115	0.00496	CbGeAlD
Sunitinib—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00115	0.0071	CcSEcCtD
Sunitinib—CSNK1E—cortex of kidney—focal segmental glomerulosclerosis	0.00115	0.00494	CbGeAlD
Sunitinib—FGFR1—cortex of kidney—focal segmental glomerulosclerosis	0.00115	0.00494	CbGeAlD
Sunitinib—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00703	CcSEcCtD
Sunitinib—MAP2K2—kidney—focal segmental glomerulosclerosis	0.00114	0.00489	CbGeAlD
Sunitinib—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00697	CcSEcCtD
Sunitinib—Dermatitis bullous—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00694	CcSEcCtD
Sunitinib—FYN—nephron tubule—focal segmental glomerulosclerosis	0.00112	0.00482	CbGeAlD
Sunitinib—ULK3—cortex of kidney—focal segmental glomerulosclerosis	0.00111	0.00476	CbGeAlD
Sunitinib—MAP2K2—cortex of kidney—focal segmental glomerulosclerosis	0.00111	0.00476	CbGeAlD
Sunitinib—TBK1—kidney—focal segmental glomerulosclerosis	0.00111	0.00475	CbGeAlD
Sunitinib—Cardiac failure—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0068	CcSEcCtD
Sunitinib—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0068	CcSEcCtD
Sunitinib—TYK2—kidney—focal segmental glomerulosclerosis	0.0011	0.00472	CbGeAlD
Sunitinib—MAP3K3—nephron tubule—focal segmental glomerulosclerosis	0.0011	0.00471	CbGeAlD
Sunitinib—MAP3K7—cortex of kidney—focal segmental glomerulosclerosis	0.00109	0.00468	CbGeAlD
Sunitinib—TBK1—cortex of kidney—focal segmental glomerulosclerosis	0.00108	0.00463	CbGeAlD
Sunitinib—TYK2—cortex of kidney—focal segmental glomerulosclerosis	0.00107	0.0046	CbGeAlD
Sunitinib—RPS6KB1—kidney—focal segmental glomerulosclerosis	0.00107	0.00457	CbGeAlD
Sunitinib—FLT1—nephron tubule—focal segmental glomerulosclerosis	0.00106	0.00455	CbGeAlD
Sunitinib—RET—kidney—focal segmental glomerulosclerosis	0.00106	0.00454	CbGeAlD
Sunitinib—IRAK1—cortex of kidney—focal segmental glomerulosclerosis	0.00106	0.00454	CbGeAlD
Sunitinib—RPS6KB1—cortex of kidney—focal segmental glomerulosclerosis	0.00104	0.00445	CbGeAlD
Sunitinib—AXL—cortex of kidney—focal segmental glomerulosclerosis	0.00103	0.00441	CbGeAlD
Sunitinib—YES1—nephron tubule—focal segmental glomerulosclerosis	0.00101	0.00435	CbGeAlD
Sunitinib—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00622	CcSEcCtD
Sunitinib—FGFR2—kidney—focal segmental glomerulosclerosis	0.00101	0.00432	CbGeAlD
Sunitinib—JAK2—kidney—focal segmental glomerulosclerosis	0.001	0.00429	CbGeAlD
Sunitinib—TAOK3—nephron tubule—focal segmental glomerulosclerosis	0.001	0.00429	CbGeAlD
Sunitinib—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.00608	CcSEcCtD
Sunitinib—SLK—cortex of kidney—focal segmental glomerulosclerosis	0.000988	0.00424	CbGeAlD
Sunitinib—FYN—kidney—focal segmental glomerulosclerosis	0.000987	0.00423	CbGeAlD
Sunitinib—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.000986	0.00606	CcSEcCtD
Sunitinib—CYP3A7-CYP3A51P—nephron tubule—focal segmental glomerulosclerosis	0.000978	0.0042	CbGeAlD
Sunitinib—JAK2—cortex of kidney—focal segmental glomerulosclerosis	0.000974	0.00418	CbGeAlD
Sunitinib—FYN—cortex of kidney—focal segmental glomerulosclerosis	0.000961	0.00412	CbGeAlD
Sunitinib—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.000952	0.00585	CcSEcCtD
Sunitinib—MAP4K5—cortex of kidney—focal segmental glomerulosclerosis	0.000939	0.00403	CbGeAlD
Sunitinib—MAP3K3—cortex of kidney—focal segmental glomerulosclerosis	0.000939	0.00403	CbGeAlD
Sunitinib—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.000939	0.00578	CcSEcCtD
Sunitinib—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.000933	0.00574	CcSEcCtD
Sunitinib—FLT1—kidney—focal segmental glomerulosclerosis	0.000932	0.004	CbGeAlD
Sunitinib—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000914	0.00562	CcSEcCtD
Sunitinib—FLT1—cortex of kidney—focal segmental glomerulosclerosis	0.000908	0.0039	CbGeAlD
Sunitinib—EPHB6—cortex of kidney—focal segmental glomerulosclerosis	0.000898	0.00385	CbGeAlD
Sunitinib—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.000897	0.00552	CcSEcCtD
Sunitinib—KDR—nephron tubule—focal segmental glomerulosclerosis	0.000897	0.00385	CbGeAlD
Sunitinib—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000894	0.0055	CcSEcCtD
Sunitinib—YES1—kidney—focal segmental glomerulosclerosis	0.000891	0.00382	CbGeAlD
Sunitinib—STK10—kidney—focal segmental glomerulosclerosis	0.000883	0.00379	CbGeAlD
Sunitinib—TAOK3—kidney—focal segmental glomerulosclerosis	0.000879	0.00377	CbGeAlD
Sunitinib—YES1—cortex of kidney—focal segmental glomerulosclerosis	0.000867	0.00372	CbGeAlD
Sunitinib—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.00533	CcSEcCtD
Sunitinib—TAOK3—cortex of kidney—focal segmental glomerulosclerosis	0.000856	0.00367	CbGeAlD
Sunitinib—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.000844	0.00519	CcSEcCtD
Sunitinib—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000841	0.00517	CcSEcCtD
Sunitinib—CYP3A7-CYP3A51P—cortex of kidney—focal segmental glomerulosclerosis	0.000837	0.00359	CbGeAlD
Sunitinib—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.000836	0.00514	CcSEcCtD
Sunitinib—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.00511	CcSEcCtD
Sunitinib—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.000832	0.00511	CcSEcCtD
Sunitinib—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.000829	0.0051	CcSEcCtD
Sunitinib—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00082	0.00504	CcSEcCtD
Sunitinib—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000817	0.00503	CcSEcCtD
Sunitinib—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000815	0.00501	CcSEcCtD
Sunitinib—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000811	0.00499	CcSEcCtD
Sunitinib—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000808	0.00497	CcSEcCtD
Sunitinib—KIT—nephron tubule—focal segmental glomerulosclerosis	0.000795	0.00341	CbGeAlD
Sunitinib—KDR—kidney—focal segmental glomerulosclerosis	0.000788	0.00338	CbGeAlD
Sunitinib—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000787	0.00484	CcSEcCtD
Sunitinib—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000784	0.00482	CcSEcCtD
Sunitinib—KDR—cortex of kidney—focal segmental glomerulosclerosis	0.000768	0.00329	CbGeAlD
Sunitinib—MAP2K5—cortex of kidney—focal segmental glomerulosclerosis	0.000768	0.00329	CbGeAlD
Sunitinib—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00075	0.00462	CcSEcCtD
Sunitinib—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000747	0.00459	CcSEcCtD
Sunitinib—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.000747	0.00459	CcSEcCtD
Sunitinib—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.00457	CcSEcCtD
Sunitinib—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000737	0.00453	CcSEcCtD
Sunitinib—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000734	0.00451	CcSEcCtD
Sunitinib—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.0045	CcSEcCtD
Sunitinib—KIT—kidney—focal segmental glomerulosclerosis	0.000698	0.003	CbGeAlD
Sunitinib—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000693	0.00426	CcSEcCtD
Sunitinib—PDGFRB—kidney—focal segmental glomerulosclerosis	0.000682	0.00293	CbGeAlD
Sunitinib—KIT—cortex of kidney—focal segmental glomerulosclerosis	0.00068	0.00292	CbGeAlD
Sunitinib—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000677	0.00417	CcSEcCtD
Sunitinib—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000673	0.00414	CcSEcCtD
Sunitinib—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00067	0.00412	CcSEcCtD
Sunitinib—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.0041	CcSEcCtD
Sunitinib—PDGFRB—cortex of kidney—focal segmental glomerulosclerosis	0.000664	0.00285	CbGeAlD
Sunitinib—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00066	0.00406	CcSEcCtD
Sunitinib—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000654	0.00402	CcSEcCtD
Sunitinib—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00065	0.004	CcSEcCtD
Sunitinib—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00394	CcSEcCtD
Sunitinib—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000636	0.00391	CcSEcCtD
Sunitinib—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00384	CcSEcCtD
Sunitinib—ABCC4—nephron tubule—focal segmental glomerulosclerosis	0.000618	0.00265	CbGeAlD
Sunitinib—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.00369	CcSEcCtD
Sunitinib—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.000598	0.00257	CbGeAlD
Sunitinib—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000594	0.00365	CcSEcCtD
Sunitinib—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000582	0.00358	CcSEcCtD
Sunitinib—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000567	0.00349	CcSEcCtD
Sunitinib—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000563	0.00346	CcSEcCtD
Sunitinib—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000561	0.00345	CcSEcCtD
Sunitinib—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.0034	CcSEcCtD
Sunitinib—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.0034	CcSEcCtD
Sunitinib—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000553	0.0034	CcSEcCtD
Sunitinib—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000549	0.00338	CcSEcCtD
Sunitinib—ABCC4—kidney—focal segmental glomerulosclerosis	0.000543	0.00233	CbGeAlD
Sunitinib—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000541	0.00333	CcSEcCtD
Sunitinib—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00326	CcSEcCtD
Sunitinib—ABCC4—cortex of kidney—focal segmental glomerulosclerosis	0.000529	0.00227	CbGeAlD
Sunitinib—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.000527	0.00324	CcSEcCtD
Sunitinib—ABCC2—kidney—focal segmental glomerulosclerosis	0.000526	0.00226	CbGeAlD
Sunitinib—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00052	0.0032	CcSEcCtD
Sunitinib—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000519	0.00319	CcSEcCtD
Sunitinib—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000515	0.00317	CcSEcCtD
Sunitinib—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.000512	0.0022	CbGeAlD
Sunitinib—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000506	0.00311	CcSEcCtD
Sunitinib—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000483	0.00297	CcSEcCtD
Sunitinib—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00048	0.00295	CcSEcCtD
Sunitinib—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000476	0.00293	CcSEcCtD
Sunitinib—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000473	0.00291	CcSEcCtD
Sunitinib—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000467	0.00287	CcSEcCtD
Sunitinib—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00284	CcSEcCtD
Sunitinib—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000458	0.00282	CcSEcCtD
Sunitinib—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000457	0.00281	CcSEcCtD
Sunitinib—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00279	CcSEcCtD
Sunitinib—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.000454	0.00279	CcSEcCtD
Sunitinib—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.000436	0.00187	CbGeAlD
Sunitinib—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000434	0.00267	CcSEcCtD
Sunitinib—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00258	CcSEcCtD
Sunitinib—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000419	0.00258	CcSEcCtD
Sunitinib—CYP3A5—nephron tubule—focal segmental glomerulosclerosis	0.000405	0.00174	CbGeAlD
Sunitinib—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000391	0.0024	CcSEcCtD
Sunitinib—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000381	0.00234	CcSEcCtD
Sunitinib—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000375	0.00231	CcSEcCtD
Sunitinib—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000363	0.00223	CcSEcCtD
Sunitinib—CYP3A5—kidney—focal segmental glomerulosclerosis	0.000356	0.00153	CbGeAlD
Sunitinib—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000351	0.00216	CcSEcCtD
Sunitinib—CYP3A5—cortex of kidney—focal segmental glomerulosclerosis	0.000347	0.00149	CbGeAlD
Sunitinib—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000337	0.00207	CcSEcCtD
Sunitinib—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00206	CcSEcCtD
Sunitinib—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000334	0.00205	CcSEcCtD
Sunitinib—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000332	0.00204	CcSEcCtD
Sunitinib—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000315	0.00194	CcSEcCtD
Sunitinib—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000267	0.00115	CbGeAlD
Sunitinib—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000215	0.000923	CbGeAlD
Sunitinib—ABCB1—kidney—focal segmental glomerulosclerosis	0.000189	0.000811	CbGeAlD
Sunitinib—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000184	0.00079	CbGeAlD
Sunitinib—PDGFRB—Disease—LPL—focal segmental glomerulosclerosis	1.22e-05	3.94e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.22e-05	3.94e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.22e-05	3.94e-05	CbGpPWpGaD
Sunitinib—FGFR1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.19e-05	3.84e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.19e-05	3.83e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—MMP9—focal segmental glomerulosclerosis	1.19e-05	3.83e-05	CbGpPWpGaD
Sunitinib—STK11—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.18e-05	3.82e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.18e-05	3.8e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—LPL—focal segmental glomerulosclerosis	1.18e-05	3.8e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.17e-05	3.79e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.17e-05	3.78e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—LPL—focal segmental glomerulosclerosis	1.17e-05	3.78e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.16e-05	3.76e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.16e-05	3.74e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.16e-05	3.74e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.15e-05	3.73e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—NOS2—focal segmental glomerulosclerosis	1.15e-05	3.72e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.15e-05	3.7e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—NOS2—focal segmental glomerulosclerosis	1.14e-05	3.68e-05	CbGpPWpGaD
Sunitinib—INSR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.14e-05	3.68e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—CTGF—focal segmental glomerulosclerosis	1.14e-05	3.67e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.14e-05	3.67e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.14e-05	3.67e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.14e-05	3.67e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	1.13e-05	3.66e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.13e-05	3.65e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.12e-05	3.63e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—LPL—focal segmental glomerulosclerosis	1.12e-05	3.61e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—NOS2—focal segmental glomerulosclerosis	1.12e-05	3.61e-05	CbGpPWpGaD
Sunitinib—ABCG2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	1.11e-05	3.6e-05	CbGpPWpGaD
Sunitinib—ABCC4—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.11e-05	3.59e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.11e-05	3.58e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.11e-05	3.57e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.1e-05	3.57e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.1e-05	3.55e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.1e-05	3.54e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.1e-05	3.54e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.09e-05	3.53e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.09e-05	3.52e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.09e-05	3.52e-05	CbGpPWpGaD
Sunitinib—CSNK2A1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.08e-05	3.49e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.08e-05	3.49e-05	CbGpPWpGaD
Sunitinib—FLT4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.08e-05	3.49e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.07e-05	3.44e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.07e-05	3.44e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.07e-05	3.44e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.06e-05	3.43e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—NOS2—focal segmental glomerulosclerosis	1.06e-05	3.43e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—NOS2—focal segmental glomerulosclerosis	1.06e-05	3.42e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.06e-05	3.41e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.05e-05	3.4e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.05e-05	3.39e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.05e-05	3.39e-05	CbGpPWpGaD
Sunitinib—PAK3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.05e-05	3.39e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.05e-05	3.38e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.05e-05	3.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	1.04e-05	3.36e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1.04e-05	3.36e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.04e-05	3.34e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.03e-05	3.34e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.03e-05	3.34e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.03e-05	3.34e-05	CbGpPWpGaD
Sunitinib—FYN—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.03e-05	3.32e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.03e-05	3.31e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	1.02e-05	3.31e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.02e-05	3.3e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.02e-05	3.3e-05	CbGpPWpGaD
Sunitinib—FYN—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.01e-05	3.26e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.01e-05	3.26e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1e-05	3.24e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1e-05	3.24e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	1e-05	3.24e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.97e-06	3.22e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Disease—TGFB1—focal segmental glomerulosclerosis	9.96e-06	3.21e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.87e-06	3.19e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.81e-06	3.17e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.79e-06	3.16e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.79e-06	3.16e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.78e-06	3.16e-05	CbGpPWpGaD
Sunitinib—JAK2—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	9.78e-06	3.16e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—NOS2—focal segmental glomerulosclerosis	9.78e-06	3.16e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—SERPINE1—focal segmental glomerulosclerosis	9.71e-06	3.14e-05	CbGpPWpGaD
Sunitinib—PRKAA2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.68e-06	3.13e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.67e-06	3.12e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.61e-06	3.1e-05	CbGpPWpGaD
Sunitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.6e-06	3.1e-05	CbGpPWpGaD
Sunitinib—JAK2—Hemostasis—TGFB1—focal segmental glomerulosclerosis	9.6e-06	3.1e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—SERPINE1—focal segmental glomerulosclerosis	9.59e-06	3.1e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—NOS2—focal segmental glomerulosclerosis	9.54e-06	3.08e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	9.53e-06	3.08e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.52e-06	3.07e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.5e-06	3.07e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.5e-06	3.07e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—LPL—focal segmental glomerulosclerosis	9.49e-06	3.06e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—SERPINE1—focal segmental glomerulosclerosis	9.42e-06	3.04e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.41e-06	3.04e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	9.34e-06	3.01e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—NOS2—focal segmental glomerulosclerosis	9.2e-06	2.97e-05	CbGpPWpGaD
Sunitinib—RPS6KA5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.15e-06	2.95e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—NOS2—focal segmental glomerulosclerosis	9.15e-06	2.95e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	9.11e-06	2.94e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9.06e-06	2.93e-05	CbGpPWpGaD
Sunitinib—RPS6KA2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	9.06e-06	2.92e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	9.03e-06	2.92e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	9.01e-06	2.91e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	9e-06	2.91e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.99e-06	2.9e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—SERPINE1—focal segmental glomerulosclerosis	8.94e-06	2.89e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—SERPINE1—focal segmental glomerulosclerosis	8.92e-06	2.88e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.88e-06	2.87e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.85e-06	2.86e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.82e-06	2.85e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.76e-06	2.83e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—NOS2—focal segmental glomerulosclerosis	8.74e-06	2.82e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.74e-06	2.82e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.73e-06	2.82e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.73e-06	2.82e-05	CbGpPWpGaD
Sunitinib—CSNK1A1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.63e-06	2.79e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.58e-06	2.77e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.58e-06	2.77e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.55e-06	2.76e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	8.51e-06	2.75e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.5e-06	2.74e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	8.46e-06	2.73e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.45e-06	2.73e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.42e-06	2.72e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.3e-06	2.68e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.24e-06	2.66e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—SERPINE1—focal segmental glomerulosclerosis	8.23e-06	2.66e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	8.22e-06	2.65e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	8.2e-06	2.65e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.17e-06	2.64e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.14e-06	2.63e-05	CbGpPWpGaD
Sunitinib—RPS6KA1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.14e-06	2.63e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—AGT—focal segmental glomerulosclerosis	8.12e-06	2.62e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	8.1e-06	2.62e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	8.08e-06	2.61e-05	CbGpPWpGaD
Sunitinib—FLT1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.07e-06	2.61e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	8.07e-06	2.61e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—SERPINE1—focal segmental glomerulosclerosis	8.03e-06	2.59e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—LPL—focal segmental glomerulosclerosis	7.95e-06	2.57e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.94e-06	2.56e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.93e-06	2.56e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.93e-06	2.56e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—LPL—focal segmental glomerulosclerosis	7.88e-06	2.54e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.86e-06	2.54e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.84e-06	2.53e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.81e-06	2.52e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.77e-06	2.51e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—SERPINE1—focal segmental glomerulosclerosis	7.74e-06	2.5e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—SERPINE1—focal segmental glomerulosclerosis	7.7e-06	2.49e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	7.57e-06	2.44e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.52e-06	2.43e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—FN1—focal segmental glomerulosclerosis	7.5e-06	2.42e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.5e-06	2.42e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	7.42e-06	2.4e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.39e-06	2.38e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—SERPINE1—focal segmental glomerulosclerosis	7.36e-06	2.38e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.32e-06	2.36e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	7.21e-06	2.33e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.05e-06	2.28e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	7.05e-06	2.27e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	7.01e-06	2.26e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	7.01e-06	2.26e-05	CbGpPWpGaD
Sunitinib—CSNK1E—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.97e-06	2.25e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.94e-06	2.24e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.93e-06	2.24e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.9e-06	2.23e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—AGT—focal segmental glomerulosclerosis	6.8e-06	2.2e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.8e-06	2.2e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.76e-06	2.18e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—AGT—focal segmental glomerulosclerosis	6.74e-06	2.18e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.72e-06	2.17e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.7e-06	2.16e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.69e-06	2.16e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.69e-06	2.16e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.6e-06	2.13e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.6e-06	2.13e-05	CbGpPWpGaD
Sunitinib—PRKAA1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.54e-06	2.11e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	6.52e-06	2.1e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.52e-06	2.1e-05	CbGpPWpGaD
Sunitinib—RPS6KA3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	6.48e-06	2.09e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.48e-06	2.09e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.26e-06	2.02e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	6.24e-06	2.02e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	6.2e-06	2e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	6.19e-06	2e-05	CbGpPWpGaD
Sunitinib—TYK2—Disease—TGFB1—focal segmental glomerulosclerosis	6.13e-06	1.98e-05	CbGpPWpGaD
Sunitinib—FGFR2—Disease—TGFB1—focal segmental glomerulosclerosis	6.06e-06	1.95e-05	CbGpPWpGaD
Sunitinib—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	6.03e-06	1.95e-05	CbGpPWpGaD
Sunitinib—KIT—Disease—TGFB1—focal segmental glomerulosclerosis	5.95e-06	1.92e-05	CbGpPWpGaD
Sunitinib—PTK2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.94e-06	1.92e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.76e-06	1.86e-05	CbGpPWpGaD
Sunitinib—ROCK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.72e-06	1.85e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.71e-06	1.84e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	5.7e-06	1.84e-05	CbGpPWpGaD
Sunitinib—NTRK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.68e-06	1.83e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.66e-06	1.83e-05	CbGpPWpGaD
Sunitinib—FGFR1—Disease—TGFB1—focal segmental glomerulosclerosis	5.64e-06	1.82e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Disease—TGFB1—focal segmental glomerulosclerosis	5.63e-06	1.82e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.63e-06	1.82e-05	CbGpPWpGaD
Sunitinib—RPS6KB1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.51e-06	1.78e-05	CbGpPWpGaD
Sunitinib—MAP2K5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.51e-06	1.78e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.42e-06	1.75e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.39e-06	1.74e-05	CbGpPWpGaD
Sunitinib—KDR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	5.37e-06	1.73e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.37e-06	1.73e-05	CbGpPWpGaD
Sunitinib—ABCG2—Metabolism—ALB—focal segmental glomerulosclerosis	5.22e-06	1.69e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.21e-06	1.68e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Disease—TGFB1—focal segmental glomerulosclerosis	5.2e-06	1.68e-05	CbGpPWpGaD
Sunitinib—CYP3A7—Metabolism—ALB—focal segmental glomerulosclerosis	5.17e-06	1.67e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	5.15e-06	1.66e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.15e-06	1.66e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Disease—TGFB1—focal segmental glomerulosclerosis	5.07e-06	1.64e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.05e-06	1.63e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	5.05e-06	1.63e-05	CbGpPWpGaD
Sunitinib—FYN—Disease—TGFB1—focal segmental glomerulosclerosis	4.89e-06	1.58e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	4.87e-06	1.57e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Disease—TGFB1—focal segmental glomerulosclerosis	4.86e-06	1.57e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.8e-06	1.55e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.78e-06	1.54e-05	CbGpPWpGaD
Sunitinib—YES1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.66e-06	1.51e-05	CbGpPWpGaD
Sunitinib—JAK2—Disease—TGFB1—focal segmental glomerulosclerosis	4.65e-06	1.5e-05	CbGpPWpGaD
Sunitinib—IRAK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.42e-06	1.43e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.42e-06	1.43e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	4.34e-06	1.4e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.31e-06	1.39e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	4.3e-06	1.39e-05	CbGpPWpGaD
Sunitinib—TYK2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.29e-06	1.39e-05	CbGpPWpGaD
Sunitinib—FGFR2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.24e-06	1.37e-05	CbGpPWpGaD
Sunitinib—MAP3K7—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.16e-06	1.34e-05	CbGpPWpGaD
Sunitinib—KIT—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	4.16e-06	1.34e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.15e-06	1.34e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	4.13e-06	1.33e-05	CbGpPWpGaD
Sunitinib—FGFR1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.95e-06	1.28e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.95e-06	1.27e-05	CbGpPWpGaD
Sunitinib—PDGFRA—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.94e-06	1.27e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	3.82e-06	1.23e-05	CbGpPWpGaD
Sunitinib—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	3.74e-06	1.21e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	3.68e-06	1.19e-05	CbGpPWpGaD
Sunitinib—MAP2K2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.64e-06	1.17e-05	CbGpPWpGaD
Sunitinib—PDGFRB—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.55e-06	1.15e-05	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.52e-06	1.14e-05	CbGpPWpGaD
Sunitinib—FYN—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.42e-06	1.11e-05	CbGpPWpGaD
Sunitinib—MAP2K1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.4e-06	1.1e-05	CbGpPWpGaD
Sunitinib—JAK2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.25e-06	1.05e-05	CbGpPWpGaD
Sunitinib—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	2.82e-06	9.11e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	2.65e-06	8.55e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	2.27e-06	7.32e-06	CbGpPWpGaD
Sunitinib—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	1.74e-06	5.61e-06	CbGpPWpGaD
